tiprankstipranks
Advertisement
Advertisement

TSE:BNXT Stock Latest News

BioNxt Boosts Investor Relations Efforts With New Mandates and 5.15 Million Option Grants
Company AnnouncementsBioNxt Boosts Investor Relations Efforts With New Mandates and 5.15 Million Option Grants
1M ago
BioNxt Wipes Out $2.7 Million Debt Through Share Issuance
PremiumCompany Announcements
BioNxt Wipes Out $2.7 Million Debt Through Share Issuance
1M ago
BioNxt Moves to Retire $2.7 Million in Debenture Debt via Share Issuance
PremiumCompany Announcements
BioNxt Moves to Retire $2.7 Million in Debenture Debt via Share Issuance
3M ago
BioNxt’s Sublingual Cladribine Film Delivers 40% Higher Exposure in Preclinical MS Study
PremiumCompany Announcements
BioNxt’s Sublingual Cladribine Film Delivers 40% Higher Exposure in Preclinical MS Study
3M ago
BioNxt’s Cladribine Film Shows Superior Bioavailability in Preclinical MS Study
PremiumCompany Announcements
BioNxt’s Cladribine Film Shows Superior Bioavailability in Preclinical MS Study
3M ago
BioNxt Advances Thin-Film Drug Platform With First Patent for Sublingual Cladribine
PremiumCompany AnnouncementsBioNxt Advances Thin-Film Drug Platform With First Patent for Sublingual Cladribine
3M ago
BioNxt Signs Agreement for Sublingual Chemotherapy and Immunosuppressant Innovation
Premium
Company Announcements
BioNxt Signs Agreement for Sublingual Chemotherapy and Immunosuppressant Innovation
4M ago
BioNxt Secures Eurasian Patent for Sublingual Cladribine Platform
Premium
Company Announcements
BioNxt Secures Eurasian Patent for Sublingual Cladribine Platform
4M ago
BioNxt Unveils Innovative Oral Film to Transform MS Treatment
PremiumCompany Announcements
BioNxt Unveils Innovative Oral Film to Transform MS Treatment
4M ago
BioNxt Secures Eurasian Patent Readiness for Sublingual Drug Delivery
PremiumCompany Announcements
BioNxt Secures Eurasian Patent Readiness for Sublingual Drug Delivery
5M ago
BioNxt Secures European Patent for Innovative MS Treatment
PremiumCompany Announcements
BioNxt Secures European Patent for Innovative MS Treatment
5M ago
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
PremiumCompany Announcements
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
5M ago
BioNxt Solutions Advances Cladribine Formulation with New Study
PremiumCompany AnnouncementsBioNxt Solutions Advances Cladribine Formulation with New Study
5M ago
BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization
Premium
TipRanks Newswire
BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization
5M ago
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
Premium
TipRanks Newswire
BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug
6M ago
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
PremiumTipRanks Newswire
BioNxt Launches 15-day Sublingual Cladribine Dosing Optimization Study in Preparation for Human Bioequivalence Study
6M ago
BioNxt Advances Cladribine Sublingual Film for MS Treatment
PremiumCompany Announcements
BioNxt Advances Cladribine Sublingual Film for MS Treatment
6M ago
BioNxt Solutions Adapts AGM Voting Amid Postal Strike and Launches Marketing Campaign
PremiumCompany Announcements
BioNxt Solutions Adapts AGM Voting Amid Postal Strike and Launches Marketing Campaign
6M ago
BioNxt Advances Semaglutide Oral Film with Successful Trials
PremiumCompany Announcements
BioNxt Advances Semaglutide Oral Film with Successful Trials
6M ago
BioNxt Advances Targeted Chemotherapy Delivery Platform
PremiumCompany AnnouncementsBioNxt Advances Targeted Chemotherapy Delivery Platform
6M ago
BioNxt Solutions Strengthens Market Position with Strategic Advisor and Investor Relations Team
Premium
Company Announcements
BioNxt Solutions Strengthens Market Position with Strategic Advisor and Investor Relations Team
6M ago
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
Premium
Company Announcements
BioNxt Solutions Completes Debt Settlement to Strengthen Financial Position
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >